Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation and other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
258
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Cogent Biosciences Inc market cap is $4.65B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cogent Biosciences Inc 52 week high is $43.73 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cogent Biosciences Inc 52 week low is $26.36 as of November 22, 2026.
Cogent Biosciences Inc stock price today is $26.72.
Cogent Biosciences Inc stock price yesterday was $27.74.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Cogent Biosciences Inc's P/E ratio is -10.68.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Cogent Biosciences Inc P/B ratio is 10.297.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Cogent Biosciences Inc 50-day moving average is $30.71.